Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony S. Kim, MD, MAS
University of California, San Francisco
Principal Investigator - J. Donald Easton, MD
University of California, San Francisco
Principal Investigator - S. Claiborne Johnston, MD, PhD
University of Texas at Austin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
210 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gosford Hospital
Gosford, New South Wales, Australia
- John Hunter Hospital
New Lambton, New South Wales, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- the Northern Hospital
Epping, Victoria, Australia
- Footscray Hospital
Footscray, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- University of Calgary - Foothills Campus
Calgary, Alberta, Canada
- Grey Nuns Hospital
Edmonton, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- London Health Sciences Center
London, Ontario, Canada
- Charles Lemoyne Hospital
Greenfield Park, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Notre-Dame Hospital
Montreal, Quebec, Canada
- Enfant-Jesus Hospital
Québec, Canada
- Helsinki University Central Hospital
Helsinki, Finland
- Turku University Hospital
Turku, Finland
- Fleyriat Hospital
Bourg-en-Bresse, France
- Pierre Wetheimer Hospital
Bron, France
- Adolphe de Rothschild Ophthalmologic Foundation
Paris, France
- Bichat-Claude Bernard Hospital
Paris, France
- Pitie-Salpetriere Hospital
Paris, France
- Foch Hospital
Suresnes, France
- University Hospital of Ulm
Ulm, Baden-Wurttemberg, Germany
- Neurological Clinic Bad Neustadt
Bad Neustadt an der Saale, Germany
- Vivantes Hospital Neukolln
Berlin, Germany
- Central Bremen Hospital
Bremen, Germany
- University Hospital Essen
Essen, Germany
- University Hospital Frankfurt
Frankfurt, Germany
- University Medical Center Hamburg
Hamburg, Germany
- Hannover Medical School
Hanover, Germany
- University Hospital Heidelberg
Heidelberg, Germany
- University Hospital Schleswig-Holstein Kiel Campus
Kiel, Germany
- University Medical Center Leipzig
Leipzig, Germany
- University Hospital Munster
Münster, Germany
- Mexican Association for Clinical Research
Pachuca, Hidalgo, Mexico
- Central Hospital Dr. Ignacio Morones Prieto
San Luis Potosí City, San Luis Potosí, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 May 2010
- Primary completion
- 9 Apr 2018
- Completion
- 9 Apr 2018
- Last update posted
- 4 Dec 2018
- Registered enrollment
- 4,881
- Registry id
- NCT00991029
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.